Taken together, our findings suggest that COVID-19 may be associated with shifts in the distribution of ON subtypes—particularly an increased occurrence of ADEM-ON and absence of AQP4-ON—potentially reflecting a distinct autoimmune mechanism from that of classical NMOSD. Here, AQP4 is linked to COVID-19.